RussellD.H., LevyC.C., SchimpffS.C., HawkI.A.. Urinary polyamines in cancer patients.Cancer Res1971; 31: 1555–8.
2.
BachrachU.. Polyamines as markers of malignancy.Prog Drug Res1992; 39: 9–33.
3.
HiramatsuK., SugimotoM., KameiS.. Determination of amounts of polyamines excreted in urine; demonstration of N1, N8-diacetylspermidine and N1, N12-diacetylspermine as components commonly occurring in normal human urine.J Biochem1995; 117: 107–12.
4.
HiramatsuK., SugimotoM., KameiS.. Diagnostic and prognostic usefulness of N1, N8-diacetylspermidine and N1, N12-diacetylspermine in urine as novel markers of malignancy.J Cancer Res Clin Oncol1997; 123: 539–45.
5.
HiramatsuK., MiuraH., KameiS.. Development of sensitive and accurate enzyme-linked immunosorbent assay (ELISA) system that can replace HPLC analysis for the detection of N1, N12-diacetylspermidine in human urine.J Biochem1998; 124: 231–6.
6.
HamaokiM., HiramatsuK., SuzukiS.. Two enzyme-linked immunosorbent assay (ELISA) systems for N1, N8-diacetylspermidine and N1, N12-diacetylspermine using monoclonal antibodies.J Biochem2002; 132: 783–8.
7.
EnjojiM., NakamutaM., ArimuraE.. Clinical significance of urinary N1, N12-diacetylspermine levels in patients with hepatocellular carcinoma.Int J Biol Markers2004; 19: 322–7.
8.
YamaguchiK., NakamuraM., ShirahaneK.. Urine diacetylspermine as a novel tumour marker for pancreatobiliary carcinomas.Digest Liver Dis2005; 37: 190–4.
9.
RussellD.H., LevyC.C.. Polyamine accumulation and biosynthesis in a mouse L1210 leukemia.Cancer Res1971; 31: 248–51.
10.
PösöH., PeggA.E.. Effect of α-difluoromethylornithine on polyamine and DNA synthesis in regenerating rat liver: reversal of inhibition of DNA synthesis by putrescine.Biochim Biophys Acta1982; 696: 179–8.